Biome Australia Ltd (bio) Logo

Biome Australia Ltd (BIO)

___:___ · Consumer Defensive
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

BIO Chart

Snapshot

BIO's Principal Activity is the licencing, development and marketing of complimentary medicines, including nutraceuticals and live biotheraputics.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -50.95%

Size

Market Capitalisation
ASX Rank 1,897 of 2,397
Sector Rank 72 of 95

Key Fundamentals

Shares Issued
Sector Consumer Defensive
Similar Companies OGA / FRM / LV1
EPS $0.00
DPS $0.00
NTA per share $0.00

Broker Consensus

BIO is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Biome Australia Limited (BIO) is an Australian company that primarily operates in the complementary medicine industry. The company licences, develops and markets innovative, evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics).

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Cremorne VIC 3121
Website www.biomeaustralia.com
Registry Automic Group
Auditor JTP Assurance
Date Listed 30 Nov 2021

Upcoming Calendar (Forecasted)

No calendar entries available.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Ms Dominique Gayle Fisher Non-Executive Director Aug 2021

Ms Dominique Gayle Fisher

Non-Executive Director

Ms Fisher couples her experience in tech driven businesses with a focus on risk mitigation and financial management which has led to her working in a range of sectors in both executive and nonexecutive roles including insurance, procurement, publishing, media, wholesale manufacturing, retail, biotech, e-commerce, business mobility software, performing arts, location data, digital and internet services, transport & logistics, artificial intelligence, property development, telecommunications, edtech, postal services, advertising and professional services. She has coupled her executive career mostly in technology commercialisation including AUSSAT, with non-executive career, having served on 4 ASX listed companies, IAG, Circadian Technologies/ Opthea, Pacific Brands and GrowthOps (two as Chair) including two IPOs (IAG and TGO), numerous private companies including Integrity Life Group, Sky Technologies, Paddl Co. NRMA, various government and private advisory boards at both state and federal level for both major political parties, Geoscape Australia, LaunchVic and government agencies including the Sydney Opera House, Australia Post and the Australian Council for the Arts. Ms Fisher has experience in innovation and product development including as Chair of the Victorian Government's Expert Innovation Panel, as Judge of the annual Australian Financial Review BOSS Most Innovative Companies Award for 5 years running and implementation of the Australian Government's innovation program for SMBs and emerging talent 'The National Innovation Games' May 2019 - Dec 2021. She also chairs Risk Committee.

Mr Ilario Faenza Non-Executive Chairman,Non-Executive Director Aug 2020

Mr Ilario Faenza

Non-Executive Chairman,Non-Executive Director

Mr Faenza has over 30 years of corporate and director experience in Australia, United States, New Zealand and the United Kingdom. He has built and worked with more than 30 companies over the past 30 years including roles as Chief Operating Officer, Managing Director, Executive Director, Advisor, Executive Chairman, Non-Executive Director and Non-Executive Chairman. Mr Faenza has also previously been a Director of two ASX listed companies over the past 22 years, namely ASX listed Eftel Limited and ASX Listed Tel.Pacific Limited. Mr Faenza previously has chaired the audit and risk committee and served on the remuneration committee for ASX listed Eftel Limited, served as a member of the audit and risk committee and Remuneration committee for ASX Listed Tel.Pacific Limited. Mr Faenza managed the Scheme of Arrangement for People Telecom Limited in relation to its merger with M2 Group Limited. He is also a member of Risk Committee.

Mr Blair Vega Norfolk Chief Executive Officer,Managing Director Jul 2018

Mr Blair Vega Norfolk

Chief Executive Officer,Managing Director

Mr Norfolk has more than 10 years of experience in the pharmaceutical and natural medicine industries, He now serves as Managing Director of Biome Australia. Prior to becoming the Managing Director of Biome Australia, he previously served as the Chief Operating Officer of Biome Australia. He has worked as a strategic consultant with clients in the United States, Australia and Europe. He has provided strategy, marketing and sales expertise to brands ranging across categories including complementary medicine, FMCG, and luxury designer labels in highly competitive markets. He is an advocate and spokesperson for both preventative medicine and mental health, serving on multiple national panels.

Mr George Lazarou Company Secretary N/A

Director Transactions

BIO directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
10/12/21 Blair Norfolk Buy +174,600 $0.101 $17,686 On-market trade
30/11/21 Dominique Fisher Buy +100,000 $0.121 $12,132 On-market trade

Director Interests

The current holdings of BIO directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Blair Norfolk 10/12/2021 177,317 14,162,499 N/A N/A
Dominique Fisher 30/11/2021 0 100,000 N/A N/A
Ilario Faenza 18/08/2020 N/A 1,421,809 N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Nov 24, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Ocean And Remi Pty Ltd <Cambria Partners A/C> 14,162,499 7.08%
Raymond Demaio Pty Ltd <Raymond Family A/C> 10,927,536 5.47%
Emmanual Investment Holdings Pty Ltd <LOH Family A/C> 9,602,010 4.80%
Mrs Aini Loh 6,914,130 3.46%
Mr Joshua Stanford Harris 4,884,601 2.44%
Qinet Pharma Partners Pty Ltd 4,544,203 2.27%
Mr Michael Sven Ola Oredsson 4,254,579 2.13%
Burrangong Pty Ltd <Sam Family Settlement A/C> 3,797,101 1.90%
See Breeze Consulting Pty Ltd 3,698,116 1.85%
Camanjes Pty Ltd <Camanjes No 2 A/C> 3,675,796 1.84%
Astro Superannuation Holdings Pty Ltd <Emmanuel Super Fund A/C> 3,047,287 1.52%
Ice Cold Investments Pty Ltd 3,043,478 1.52%
Mr Yuk Chung Edward Chiu 2,769,565 1.39%
Carlisle And Co Pty Ltd <Wattle Super Fund A/C> 2,536,232 1.27%
Ract Super Pty Ltd <Rand Super Fund A/C> 2,480,072 1.24%
Mrs Barbara Elizabeth Waldon & Mr Graham William Waldon <BE & GW Waldon Family A/C> 2,478,260 1.24%
Mr Alexander Cleary 2,173,913 1.09%
Micjud Pty Ltd <Chester Super Fund A/C> 2,143,478 1.07%
Mr John William Bronger 2,140,579 1.07%
Mr Ulf Winberg 1,949,275 0.98%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 0 46 43 257 281 627

Substantial Shareholders

No Substantial Shareholders for BIO in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
BIO Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.